Teva Pharmaceutical Industries Limited (TEVA) released a profit for its first quarter that Increases, from last year
The company's bottom line came in at $369 million, or $0.31 per share. This compares with $214 million, or $0.18 per share, last year.
Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $621 million or $0.53 per share for the period.
The company's revenue for the period rose 2.3% to $3.98 billion from $3.89 billion last year.
Teva Pharmaceutical Industries Limited earnings at a glance (GAAP) :
-Earnings: $369 Mln. vs. $214 Mln. last year.-EPS: $0.31 vs. $0.18 last year.-Revenue: $3.98 Bln vs. $3.89 Bln last year.
-Guidance:Full year EPS guidance: $ 2.57 To $ 2.77Full year revenue guidance: $ 16.4 B To $ 16.8 B
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.